| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |